Patents by Inventor Matthew R. Duncan

Matthew R. Duncan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5312621
    Abstract: A novel method of treating fibrotic disorders in humans comprises the administration of a sufficient quantity of a composition containing a human alpha- or beta-interferon to raise the total concentration of such interferon in the affected tissue area to about 10 to about 4.times.10.sup.7 IU per cubic centimeter. The interferons used can be naturally derived or recombinant DNA-derived. The interferon composition can be administered by any indicated conventional method and can include any pharmaceutically acceptable, interferon-compatible vehicle.
    Type: Grant
    Filed: April 20, 1992
    Date of Patent: May 17, 1994
    Assignee: Baker Cummins Dermatologicals, Inc.
    Inventors: Brian Berman, Matthew R. Duncan